Eris Lifesciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, revenue was INR 9,763.91 million compared to INR 8,670.05 million a year ago. Net income was INR 2,182.85 million compared to INR 2,148.81 million a year ago. Basic earnings per share from continuing operations was INR 16.05 compared to INR 15.8 a year ago. Diluted earnings per share from continuing operations was INR 16.03 compared to INR 15.79 a year ago.